Oscar Health (NYSE:OSCR – Get Free Report)‘s stock had its “neutral” rating reissued by Bank of America in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. They currently have a $21.00 price target on the stock, down from their prior price target of $25.00. Bank of America‘s price target indicates […]